Skip to content

About Us
Discovery Services
In Vitro
Assays

Biochemical Assays

Cell-based Assays

Electrophysiology

High Content Assays

In Vitro
Assays

Biochemical Assays

Cell-based Assays

Electrophysiology

High Content Assays

HTS &
Hit-to-Lead

Overview

HTS^PLUS & Discovery^MAXX

High-Throughput
Screening

Hit Qualification

Hit-to-Lead

HTS &
Hit-to-Lead

Overview

HTS^PLUS & Discovery^MAXX

High-Throughput
Screening

Hit Qualification

Hit-to-Lead

Innovative
Biology

iPSC Platform

Optogenetics

Organellar
Electrophysiology

RNA Biology

SARS-CoV-2 Viral
Assays

Innovative
Biology

iPSC Platform

Optogenetics

Organellar
Electrophysiology

RNA Biology

SARS-CoV-2 Viral
Assays

Screening
Collections

Axxam Collections

Compound Management

Screening
Collections

Axxam Collections

Compound Management

Integrated
Drug Discovery

Our model and partners

Integrated
Drug Discovery

Our model and partners
News & Resources
Webinars & Events
- Boot Camp Webinars
- Events
Careers
- Working at Axxam
- Job Listing
Contact Us

About Us
Discovery Services
In Vitro
Assays

Biochemical Assays

Cell-based Assays

Electrophysiology

High Content Assays

In Vitro
Assays

Biochemical Assays

Cell-based Assays

Electrophysiology

High Content Assays

HTS &
Hit-to-Lead

Overview

HTS^PLUS & Discovery^MAXX

High-Throughput
Screening

Hit Qualification

Hit-to-Lead

HTS &
Hit-to-Lead

Overview

HTS^PLUS & Discovery^MAXX

High-Throughput
Screening

Hit Qualification

Hit-to-Lead

Innovative
Biology

iPSC Platform

Optogenetics

Organellar
Electrophysiology

RNA Biology

SARS-CoV-2 Viral
Assays

Innovative
Biology

iPSC Platform

Optogenetics

Organellar
Electrophysiology

RNA Biology

SARS-CoV-2 Viral
Assays

Screening
Collections

Axxam Collections

Compound Management

Screening
Collections

Axxam Collections

Compound Management

Integrated
Drug Discovery

Our model and partners

Integrated
Drug Discovery

Our model and partners
News & Resources
Webinars & Events
- Boot Camp Webinars
- Events
Careers
- Working at Axxam
- Job Listing
Contact Us

About Us
Discovery Services
News & Resources
Webinars & Events
- Boot Camp Webinars
- Events
Careers
- Working at Axxam
- Job Listing
Contact Us

About Us
Discovery Services
News & Resources
Webinars & Events
- Boot Camp Webinars
- Events
Careers
- Working at Axxam
- Job Listing
Contact Us

Author name: ASolia

Elrig Drug Discovery

Events / ASolia

18-19 October 2023 – Liverpool, UK

Elrig Drug Discovery Read More »

BioJapan

Events / ASolia

11-13 October 2023 – Yokohama, Japan

BioJapan Read More »

RESOLUTE: Unlocking Transporters For Drug Discovery

Events / ASolia

27-29 September 2023 – Vienna, Austria

RESOLUTE: Unlocking Transporters For Drug Discovery Read More »

DOT – Discovery on Target

Events / ASolia

25-28 September 2023 – Boston, USA

DOT – Discovery on Target Read More »

Arturo Falaschi Conference on TDP-43 function and dysfunction in disease

Events / ASolia

6-8 September 2023 – Trieste, Italy

Arturo Falaschi Conference on TDP-43 function and dysfunction in disease Read More »

Ciriaco Maraschiello joins Axxam as Chief Operating Officer

Leave a Comment / News / ASolia

5 July 2023

Ciriaco Maraschiello joins Axxam as Chief Operating Officer Read More »

FDSS User Meeting

Events / ASolia

29 June 2023 – Leuven, Belgium

FDSS User Meeting Read More »

Uwe Gottschalk appointed as Board Observer

Leave a Comment / News / ASolia

15 June 2023

Uwe Gottschalk appointed as Board Observer Read More »

Assaying with iPSC-derived cardiomyocytes: setting the rhythm for early drug discovery

Webinars / ASolia

8 November 2023 – available on demand

Assaying with iPSC-derived cardiomyocytes: setting the rhythm for early drug discovery Read More »

Remove the pain, retain the gain: biophysical methods in early drug discovery

Webinars / ASolia

13 June 2023 – available on demand

Remove the pain, retain the gain: biophysical methods in early drug discovery Read More »

Post pagination

← Previous 1 2 3 … 15 Next →

Newsletter

Do you want to know what we are doing?
Subscribe to the newsletter and stay updated on news

Axxam S.p.A.

Openzone – Via Meucci, 3
20091 Bresso – Milan, Italy
Cap. Soc.: euro 137.477 i.v.
C.F./P.IVA/VAT:
IT13451210150
R.E.A. Milan 1653022

Follow us

Legal

Privacy Policy
Cookie Policy
Disclaimer

D.Lgs. n. 231 del 2001
Whistleblowing
PdR125
Quality and information security policy

Copyright © 2024 Axxam S.p.A.

Scroll to Top